Laurel Wealth Advisors (California)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.04M Buy
26,215
+4,953
+23% +$401K 0.2% 117
2022
Q3
$1.72M Buy
21,262
+15,874
+295% +$1.43M 0.18% 126
2022
Q2
$484K Sell
5,388
-963
-15% -$97.6K 0.05% 367
2022
Q1
$704K Sell
6,351
-1,677
-21% -$177K 0.06% 328
2021
Q4
$831K Buy
8,028
+5,003
+165% +$579K 0.06% 314
2021
Q3
$379K Sell
3,025
-360
-11% -$46.6K 0.07% 290
2021
Q2
$421K Buy
3,385
+272
+9% +$34.2K 0.05% 317
2021
Q1
$368K Buy
3,113
+792
+34% +$92.8K 0.06% 312
2020
Q4
$272K Buy
2,321
+59
+3% +$6.5K 0.04% 358
2020
Q3
$235K Sell
2,262
-48
-2% -$4.82K 0.04% 357
2020
Q2
$212K Buy
2,310
+42
+2% +$4.03K 0.04% 366
2020
Q1
$205K Buy
2,268
+7
+0.3% +$745 0.05% 349
2019
Q4
$256K Buy
2,261
+116
+5% +$12.7K 0.04% 384
2019
Q3
$233K Buy
+2,145
New +$224K 0.04% 402
2019
Q2
Sell
-2,349
Closed -$214K 416
2019
Q1
$214K Buy
+2,349
New +$210K 0.05% 355
2018
Q4
Sell
-2,714
Closed -$266K 396
2018
Q3
$266K Sell
2,714
-813
-23% -$75.2K 0.07% 307
2018
Q2
$301K Sell
3,527
-33
-0.9% -$2.76K 0.08% 257
2018
Q1
$285K Sell
3,560
-132
-4% -$10.9K 0.09% 253
2017
Q4
$298K Buy
+3,692
New +$296K 0.09% 253

Other funds holding MDT

Laurel Wealth Advisors (California)'s MDT Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its Medtronic (MDT) stake by 23% in Q4 2022, buying an estimated $401K and bringing the position to 26,215 shares worth $2.04M. The position accounts for 0.2% of the portfolio, ranked #117.

Laurel Wealth Advisors (California) first reported a position in MDT in Q4 2017 and has held it in 19 quarters since. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Laurel Wealth Advisors (California) held 26,215 shares of Medtronic worth $2.04M as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 4,953 Medtronic shares in Q4 2022, an estimated $401K.
  • Medtronic made up 0.2% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #117 holding.
  • Laurel Wealth Advisors (California) first reported a position in Medtronic in Q4 2017 and has held it in 19 quarters since.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.